Smart Packaging
Pharmaceutical Cold Chain Packaging Market

Pharmaceutical Cold Chain Packaging Market Size, Share, and Growth Forecast, 2025 - 2032

Q: What is the projected growth rate for the Global Pharmaceutical Cold Chain Packaging Market?

The market is expected to witness a CAGR of 14.6 % from 2025 to 2032.

Pharmaceutical Cold Chain Packaging Market by Material Type (Plastics, Paper & Paperboard, Metal, and Others (Glass, Composite Materials, etc.), Product Type (Small Boxes / Insulated Shippers, Pallet Shippers / Pallets, Large-Sized Pallet Containers, Vaccines Vials & Packaging Systems, Temperature-Controlled Bags & Pouches, and Others (Phase Change Materials, Gel Packs)), End-user, and Regional Analysis for 2025 - 2032

ID: PMRREP35890

November 2025

199 Pages

Author : Swapnil Chavan

Packaging

Preview Segmentation

Pharmaceutical Cold Chain Packaging Market Size and Trends Analysis

The global pharmaceutical cold chain packaging market size is valued at US$28.9 billion in 2025 and is projected to reach US$75.0 billion, growing at a CAGR of 14.6% during the forecast period 2025 - 2032. This robust expansion reflects accelerating demand for temperature-sensitive pharmaceutical products, including biologics, mRNA vaccines, and cell and gene therapies.

The market growth is underpinned by strengthened regulatory compliance requirements, expansion of biopharmaceutical manufacturing infrastructure in developed and emerging markets, and technological advancements in thermal packaging and IoT-enabled temperature monitoring.

As pharmaceutical companies increasingly prioritise product efficacy and supply chain integrity, cold chain packaging has transitioned from a logistics commodity to a strategic competitive advantage, particularly in high-value therapeutic categories where temperature excursions can render products ineffective or dangerous.

Key Industry Highlights:

Plastics dominate material composition, accounting for approximately 74% share, driven by EPS and EPP-based insulated shippers for temperature-sensitive pharmaceutical shipments.
Small boxes and insulated shippers lead the product type, representing around 38% market share, and are the standard for clinical trials, vial transport, and small-batch distribution.
Biopharmaceutical companies dominate end-user, holding roughly a 54% share, reflecting concentrated procurement and stringent temperature-controlled distribution requirements.
North America remains the largest regional market, with a 31% share, supported by extensive biopharmaceutical manufacturing investments, advanced cold-chain logistics, and the adoption of IoT-enabled packaging.
Europe accounts for a 27% share, driven by mature manufacturing hubs and stringent EU GDP regulations demanding premium thermal packaging and real-time monitoring capabilities.
East Asia holds a 19% share, fueled by rapid biopharmaceutical manufacturing growth, vaccine distribution expansion, and rising exports from China, South Korea, and Japan.

Key Insights	Details
Pharmaceutical Cold Chain Packaging Market Size (2025E)	US$28.9 Bn
Market Value Forecast (2032F)	US$75.0 Bn
Projected Growth (CAGR 2025 to 2032)	14.6%
Historical Market Growth (CAGR 2019 to 2024)	13.8%

global-pharmaceutical-cold-chain-packaging-market-size-2025-2032

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Surge in Biologics, mRNA Vaccines, and Advanced Therapeutics Development

The pharmaceutical landscape has undergone a fundamental transformation with the proliferation of complex biopharmaceutical molecules. Biologics, including monoclonal antibodies, recombinant proteins, and cell therapies, inherently require stringent thermal environments to maintain potency.

The emergence of mRNA vaccine platforms, exemplified by COVID-19 vaccines requiring storage at -70°C to -80°C, has created unprecedented demand for specialised ultra-cold chain infrastructure. According to market research, mRNA therapeutics are expected to capture around 55.0% of the therapeutic product category by 2025, with these vaccines demanding logistics cost premiums of up to 25% compared to traditional biologics due to cryogenic requirements.

The Pharmaceutical Cold Chain Packaging Market directly benefits as manufacturers require differentiated packaging solutions capable of maintaining precise thermal profiles across multi-day shipments.

The global development pipeline for advanced therapeutics continues expanding, with gene therapies, CAR-T cell treatments, and antibody-drug conjugates representing the fastest-growing segments. This therapeutic innovation compels packaging providers to develop next-generation solutions featuring passive thermal systems, active temperature management, and real-time monitoring capabilities.

The complexity of maintaining ultra-cold conditions throughout manufacturing, distribution, and clinical administration channels creates sustained demand for sophisticated thermal packaging engineering and validation services.

Stringent Regulatory Mandates and Good Distribution Practice (GDP) Compliance Requirements

Regulatory authorities, including the FDA, EMA, and international health organisations, have established increasingly rigorous cold chain management standards that directly mandate packaging performance specifications.

The FDA's Current Good Manufacturing Practice (cGMP) regulations require pharmaceutical companies to validate all cold chain processes, including packaging qualification and temperature-monitoring protocols, creating baseline compliance requirements that expand the addressable market.

European Union regulations under the Good Distribution Practice (GDP) guidelines, outlined in EudraLex Volume 4, establish mandatory temperature control and monitoring during transportation and storage, with non-compliance resulting in product recalls and regulatory sanctions.

These regulatory frameworks have transformed cold chain packaging from discretionary supply chain optimisation to mandatory infrastructure investment. Emerging markets are implementing similar standards; ASEAN member states are accelerating upgrades to cold-chain infrastructure to enforce compliance, creating investment incentives across the region.

Restraint - High Capital Requirements and Cost Barriers for Cold Chain Infrastructure Implementation

Cold chain packaging solutions, particularly insulated shippers and temperature-controlled systems, require substantial upfront capital investment and ongoing operational expenses that constrain adoption, especially among smaller pharmaceutical companies and emerging market participants.

Reusable thermal shipper systems demand reverse logistics networks, cleaning validation protocols, and storage infrastructure, creating total-cost-of-ownership calculations that require multi-year payback horizons. Small and medium-sized pharmaceutical enterprises, clinical research organisations operating with constrained budgets, and regional distribution partners in emerging markets face financial barriers to implementing advanced cold chain technologies.

These cost constraints limit market penetration in price-sensitive regions and smaller therapeutic segments where volume economics do not justify premium packaging investments. Additionally, cryogenic packaging solutions for ultra-cold applications (-70°C to -80°C) command 40-50% cost premiums over standard refrigerated packaging, restricting adoption to high-value biopharmaceuticals and vaccines.

Opportunity - Integration of IoT Technology and Real-Time Temperature Monitoring Systems into Packaging Ecosystems

Real-time IoT monitoring systems represent a transformative opportunity for pharmaceutical cold chain packaging market participants as regulatory requirements increasingly mandate continuous environmental tracking throughout distribution networks. Current industry practice relies heavily on passive temperature data loggers that provide post-hoc visibility, failing to enable proactive intervention during temperature excursions.

Advanced IoT solutions utilising low-power networks such as cellular, LoRaWAN, or LTE-M transmit continuous environmental data to cloud platforms, triggering automated alerts when temperatures deviate from safe thresholds. This technological convergence enables logistics teams to implement rapid response protocols, preventing product spoilage before it becomes evident upon delivery.

Integration of IoT monitoring into thermal packaging systems creates competitive differentiation for market participants offering end-to-end solutions combining passive thermal performance with active digital visibility.

World Courier, a specialty pharma logistics provider, was recently recognised at the 2024 Supply Chain Excellence Awards for pioneering real-time location monitoring (RTLM) integration, demonstrating market momentum toward digitally-enabled cold chain solutions.

Healthcare facilities and biopharmaceutical companies increasingly evaluate packaging providers on data transparency and supply chain visibility rather than thermal performance alone, reflecting the maturation of customer procurement criteria. Smart packaging solutions incorporating temperature sensors, humidity monitors, and GPS tracking devices create a value proposition that extends beyond product protection to include supply chain optimization, demand forecasting, and integrated inventory management.

Expansion of Cold Chain Distribution Networks into Emerging Markets and Underserved Healthcare Regions

Immunisation programs, particularly vaccine distribution initiatives targeting emerging markets, represent a substantial growth opportunity for cold chain packaging providers as global health organisations and national governments expand vaccination infrastructure.

WHO-supported immunisation programs require packaged vaccine volumes to increase at double-digit annual rates in regions including Sub-Saharan Africa, Southeast Asia, and South Asia, creating demand for affordable, regionally appropriate cold chain packaging solutions.

Indian cold chain networks, spanning 4 Government Medical Supply Depots, 39 state vaccine stores, 123 divisional vaccine stores, 644 district stores, and 22,674 facility-level storage points, represent a massive distribution infrastructure that requires standardised packaging solutions for vaccine supply coordination across a 6-level organisational hierarchy.

This infrastructure scale creates sustained demand for thermal packaging designed for specific regional requirements, including extended ambient-temperature tolerances in tropical climates and optimised ice-pack configurations for extended transit durations in remote delivery scenarios.

Category-wise Analysis

Material Type Insights

Plastics, primarily polystyrene foam (EPS) and expanded polypropylene (EPP), dominate the pharmaceutical cold chain packaging market, accounting for approximately 74% of the material share, due to their superior thermal insulation, cost-effectiveness, and scalability.

EPS boxes with polypropylene linings and polyethylene closures maintain pharmaceutical products within the 2°C-8°C range for extended transit, with larger containers holding compliant temperatures for up to 23 hours using strategically placed coolant packs. Thermoplastic polymers enable rapid prototyping, custom sizing, and complex designs, supporting applications from small insulated shippers for individual vials to large pallet-sized containers for bulk distribution.

The dominance of plastics reflects established manufacturing infrastructure, high-volume cost advantages, regulatory approvals, and the ability to integrate temperature monitoring, moisture barriers, structural reinforcement, and active thermal management systems.

Established converters leverage high-speed thermoforming and injection moulding equipment, supporting emerging innovations such as phase change materials and thermochromic indicators embedded in plastic panels.

Paper and paperboard materials represent the fastest-growing segment within Pharmaceutical Cold Chain Packaging Market material composition, driven by sustainability regulatory requirements and corporate environmental commitments.

Sonoco's GREENCAN® fully recyclable packaging solutions, manufactured with 92-98% paperboard content and available barrier-layer integration, demonstrate market-ready technology enabling paper-based alternatives to plastic-dominated packaging configurations.

Product Type Insights

Small boxes and insulated shippers represent the market-leading product type, accounting for approximately 38% of the pharmaceutical cold chain packaging market, representing a standard solution for individual vials, small-batch, and clinical trial material transportation.

These compact containers, typically with a payload capacity of 1-50 kilograms, provide targeted thermal management for pharmaceutical products travelling across intermediate distribution distances (48-120 hour transit duration) under refrigerated conditions.

The manufacturing process involves thermoforming or foam injection processes, creating insulated cavity structures dimensionally optimized for specific pharmaceutical product categories, with standardised interior dimensions supporting pharmaceutical vial racks, clinical trial pack configurations, and speciality drug shipments.

End-user Insights

Biopharmaceutical companies dominate the pharmaceutical cold chain packaging market, accounting for approximately 54% of end-user consumption. This leading segment includes manufacturers of biologics, monoclonal antibodies, recombinant proteins, gene therapies, cell therapies, and advanced therapeutics, all of which require temperature-controlled distribution across global supply chains.

These companies enforce stringent packaging specifications aligned with product stability profiles, regulatory compliance, and supply chain risk management protocols.

Hospitals and healthcare facilities represent the fastest-growing end-user segment, driven by the expansion of direct-to-facility pharmaceutical delivery, on-site biologic preparation, and clinical supply distribution, which previously relied on centralised pharmacy distribution centers.

global-pharmaceutical-cold-chain-packaging-market-outlook-by-material-type-2025-2032

Request Free sampleRequest Free sample

Regional Insights and Trends

North America Pharmaceutical Cold Chain Packaging Market Trends

North America maintains the largest regional market share globally, accounting for approximately 31% of the Pharmaceutical Cold Chain Packaging Market, driven by a dominant biopharmaceutical manufacturing sector and sophisticated clinical trial infrastructure. The

The United States biopharmaceutical manufacturing industry expanded substantially during 2024 - 2025, with major pharmaceutical companies announcing combined capital investments exceeding US$ 90 billion in North American facilities.

Key projects include Novo Nordisk’s US$ 4.1 billion North Carolina expansion, Johnson & Johnson’s US$ 55 billion multi-site investment program, Merck’s US$ 1 billion Durham vaccine facility, alongside additional investments by Novartis, AbbVie, and Biogen, representing unprecedented infrastructure development supporting domestic growth and export manufacturing.

The United States flexible packaging industry generated US$ 41.5 billion in sales in 2022, representing the second-largest packaging segment with 21% share of the country's US$ 180.3 billion total packaging market. Pharmaceutical and medical packaging applications constitute 16% of the US flexible packaging industry shipments, demonstrating a substantial cold chain packaging segment within the broader packaging market.

The North American market benefits from advanced cold chain logistics infrastructure; specialised third-party logistics providers operate sophisticated temperature-controlled distribution networks spanning manufacturing, clinical trial, and commercial pharmacy distribution channels.

DHL Group's 2024 acquisition of CryoPDP, a US-based speciality courier managing over 600,000 annual shipments across clinical trials and biopharmaceutical products, represents a strategic investment expanding capabilities for temperature-sensitive logistics across North American markets.

The United States represents the leading market for innovative cold chain technologies; IoT-enabled monitoring systems, advanced phase change materials, and sustainable packaging solutions achieve the earliest market penetration in North America, supporting rapid adoption-to-maturity cycles.

East Asia Pharmaceutical Cold Chain Packaging Market Trends

East Asia represents a rapidly expanding regional market, accounting for approximately 19% of the Pharmaceutical Cold Chain Packaging Market, driven by biopharmaceutical manufacturing expansion, vaccine distribution infrastructure development, and rising pharmaceutical export volumes from regional manufacturing hubs.

China and South Korea emerged as leading biopharmaceutical manufacturing centers during 2020 - 2024, with investments exceeding US$ 8 billion in new biologics manufacturing facilities supporting domestic consumption and international export.

China's pharmaceutical market is projected to reach approximately US$ 185-190 billion by 2025, with biologics and speciality pharmaceuticals representing the fastest-growing segments, commanding premium cold chain logistics infrastructure.

Europe Pharmaceutical Cold Chain Packaging Market Trends

Europe commands a significant regional market share of approximately 27% within the pharmaceutical cold chain Packaging Market, reflecting mature biopharmaceutical manufacturing infrastructure, stringent regulatory standards, and advanced healthcare distribution systems.

European pharmaceutical manufacturing represents approximately 23% of global production volume; Germany, Switzerland, Belgium, and the Netherlands maintain leading positions as biopharmaceutical production centres supporting both European consumption and international distribution.

European manufacturers maintain the highest regulatory compliance standards; EU Good Distribution Practice (GDP) requirements mandate temperature control documentation, validated packaging performance, and supply chain traceability exceeding regulatory requirements in most other regions.

This regulatory stringency creates demand for premium packaging solutions incorporating advanced temperature monitoring, real-time tracking, and comprehensive validation documentation.

global-pharmaceutical-cold-chain-packaging-market-outlook-by-region-2025-2032

Competitive Landscape

The global pharmaceutical cold chain packaging market is moderately consolidated, characterised by a mix of established global players and emerging regional suppliers focusing on specialized thermal packaging solutions.

Leading companies such as Sonoco ThermoSafe, Cold Chain Technologies, Softbox Systems (a CSafe Global company), Pelican BioThermal, and Cryopak dominate through extensive product portfolios, R&D investment, and global distribution networks.

The market is driven by innovation in temperature-controlled packaging materials, phase change technologies, and reusable systems. Regional players are increasingly gaining traction with cost-effective, sustainable, and localised cold chain packaging solutions, intensifying competition. Strategic collaborations and acquisitions are common as companies expand manufacturing capacity and enhance global supply capabilities.

Key Industry Developments:

In June 2025, Tjoapack expanded its contract packaging and cold chain storage services in the US (Clinton, Tenn.) and the Netherlands (Etten-Leur) to support growing demand for biologics, injectables, and self-administered therapies. The upgrades include high-throughput automated vial and auto-injector packaging lines, fully automated prefilled syringe (PFS) assembly, and increased GMP-compliant cold storage capacity (2-8°C), strengthening the company’s ability to serve temperature-sensitive pharmaceutical products across North America and Europe.
In July 2025, Nordic Cold Chain Solutions launched the Nordic Express Pack, the first cold chain packaging specifically designed and tested for GLP-1 medications, ensuring reliable temperature control during shipping. The solution features a compact, space-saving design, integrated temperature indicators, and ISTA-certified performance, enabling speciality pharmacies and healthcare distributors to maintain product integrity, optimise shipping efficiency, and scale operations in response to rising demand.

Companies Covered in Pharmaceutical Cold Chain Packaging Market

Sonoco Thermosafe
Sealed Air
Peli BioThermal Limited
CSafe
Intelsius
Cryoport Systems, LLC
Envirotainer
SkyCell AG
va-Q-tec AG
Inmark Global Holdings, LLC
Smurfit Westrock
Insulated Products Corporation
Chill-Pak
Practical Packaging Solutions, Inc.
TESSOL
The Wool Packaging Company Limited
Thermal Packaging Solutions Ltd.

Frequently Asked Questions

The global pharmaceutical cold chain packaging market is projected to be valued at US$ 28.9 Bn in 2025.

The Plastics segment is expected to hold around 74% market share by Material Type in 2025 in the Global Pharmaceutical Cold Chain Packaging Market, driven by superior thermal insulation, cost-effectiveness, and manufacturing scalability.

The market is expected to witness a CAGR of 14.6% from 2025 to 2032.

The Pharmaceutical Cold Chain Packaging market is driven by the surge in biologics, mRNA vaccines, advanced therapeutics, and stringent regulatory mandates requiring precise temperature-controlled distribution.

Key market opportunities in the pharmaceutical cold chain packaging market lie in integrating IoT-enabled real-time temperature monitoring systems and expanding cold chain distribution networks in emerging markets and underserved healthcare regions.

The leading global players in the pharmaceutical cold chain packaging market include Sonoco ThermoSafe, Peli BioThermal, CSafe Global, Cryoport Systems, va-Q-tec AG, and Envirotainer AB.

Report Attribute	Details
Forecast Period	2025 to 2032
Historical Data Available for	2019 to 2024
Market Analysis	USD Million for Value
Region Covered	North America Europe East Asia South Asia Oceania Latin America Middle East and Africa
Key Companies Covered	Sonoco Thermosafe Sealed Air Peli BioThermal Limited CSafe Intelsius Cryoport Systems, LLC Envirotainer SkyCell AG va-Q-tec AG Inmark Global Holdings, LLC Smurfit Westrock Insulated Products Corporation Chill-Pak Practical Packaging Solutions, Inc. TESSOL The Wool Packaging Company Limited Thermal Packaging Solutions Ltd.
Report Coverage	Market Forecast Company Share Analysis Competition Intelligence Drivers Restraints Trends and Opportunity Analysis Market Dynamics and Challenges Strategic Growth Initiatives Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Pharmaceutical Cold Chain Packaging Market Size (2025E)

US$28.9 Bn

Market Value Forecast (2032F)

US$75.0 Bn

Projected Growth (CAGR 2025 to 2032)

14.6%

Historical Market Growth (CAGR 2019 to 2024)

13.8%

Report Attribute	Details
Forecast Period	2025 to 2032
Historical Data Available for	2019 to 2024
Market Analysis	USD Million for Value
Region Covered	North America Europe East Asia South Asia Oceania Latin America Middle East and Africa
Key Companies Covered	Sonoco Thermosafe Sealed Air Peli BioThermal Limited CSafe Intelsius Cryoport Systems, LLC Envirotainer SkyCell AG va-Q-tec AG Inmark Global Holdings, LLC Smurfit Westrock Insulated Products Corporation Chill-Pak Practical Packaging Solutions, Inc. TESSOL The Wool Packaging Company Limited Thermal Packaging Solutions Ltd.
Report Coverage	Market Forecast Company Share Analysis Competition Intelligence Drivers Restraints Trends and Opportunity Analysis Market Dynamics and Challenges Strategic Growth Initiatives Market Analysis Tools

Executive Summary
1. Global Pharmaceutical Cold Chain Packaging Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Product Lifecycle Analysis
4. Global Parent Market Overview
5. Pharmaceutical Cold Chain Packaging Market: Value Chain
  1. List of Raw Product Type Supplier
  2. List of Manufacturers
  3. List of Distributors
  4. List of End Use Industries
  5. Profitability Analysis
6. Forecast Factors - Relevance and Impact
7. Covid-19 Impact Assessment
8. PESTLE Analysis
9. Porter Five Force’s Analysis
10. Geopolitical Tensions: Market Impact
11. Regulatory and Product Type Landscape
Macro-Economic Factors
1. Global Sectorial Outlook
2. Global GDP Growth Outlook
3. Other Macro-economic Factors
Price Trend Analysis, 2019 - 2032
1. Key Highlights
2. Key Factors Impacting Product Prices
3. Prices By Material Type /Product Type/End Use Industry
4. Regional Prices and Product Preferences
Global Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
  1. Market Size and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size Analysis, 2019-2024
  2. Current Market Size Forecast, 2025-2032
3. Global Pharmaceutical Cold Chain Packaging Market Outlook: Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Material Type , 2019 - 2024
  3. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
    1. Plastics
      1. Polyethylene (PE)
      2. Polypropylene (PP)
      3. Polyethylene Terephthalate (PET)
      4. Expanded Polystyrene (EPS)
      5. Polyurethane (PU)
      6. Others (PVC, PC, etc.)
    2. Paper & Paperboard
    3. Metal
    4. Others (Glass, Composite Materials, etc.)
4. Market Attractiveness Analysis: Material Type
5. Global Pharmaceutical Cold Chain Packaging MarketOutlook: Product Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Product Type, 2019 - 2024
  3. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
    1. Small Boxes / Insulated Shippers
    2. Pallet Shippers / Pallets
    3. Large-Sized Pallet Containers
    4. Vaccines Vials & Packaging Systems
    5. Temperature-Controlled Bags & Pouches
    6. Others (Phase Change Materials, Gel Packs, etc.)
6. Market Attractiveness Analysis: Product Type
7. Global Pharmaceutical Cold Chain Packaging MarketOutlook: End Use Industry
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By End Use Industry, 2019 - 2024
  3. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
    1. Biopharmaceutical Companies
    2. Clinical Research Organizations (CROs)
    3. Hospitals & Healthcare Facilities
    4. Research Institutes & Laboratories
    5. Logistics & Distribution Companies
    6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis: End Use Industry
Global Pharmaceutical Cold Chain Packaging Market Outlook Region
1. Key Highlights
2. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Region, 2019 - 2024
3. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Pharmaceutical Cold Chain Packaging MarketOutlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Country, 2025 - 2032
  1. U.S.
  2. Canada
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
Europe Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) and Volume (Tons) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. By Current Market Size (US$ Mn) Forecast By Country, 2025 - 2032
  1. Germany
  2. Italy
  3. France
  4. U.K.
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
East Asia Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. Current Market Size (US$ Mn) Forecast By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
South Asia & Oceania Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. Current Market Size (US$ Mn) Forecast By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
Latin America Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. Current Market Size (US$ Mn) Forecast By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
Middle East & Africa Pharmaceutical Cold Chain Packaging Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
1. Key Highlights
2. Pricing Analysis
3. Historical Market Size (US$ Mn) Analysis By Market, 2019 - 2024
  1. By Country
  2. By Material Type
  3. By Product Type
  4. By End Use Industry
4. Current Market Size (US$ Mn) Forecast By Country, 2025 - 2032
  1. GCC Countries
  2. South Africa
  3. Northern Africa
  4. Rest of MEA
5. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Material Type, 2025 - 2032
  1. Plastics
    1. Polyethylene (PE)
    2. Polypropylene (PP)
    3. Polyethylene Terephthalate (PET)
    4. Expanded Polystyrene (EPS)
    5. Polyurethane (PU)
    6. Others (PVC, PC, etc.)
  2. Paper & Paperboard
  3. Metal
  4. Others (Glass, Composite Materials, etc.)
6. Current Market Size (US$ Mn) and Volume (Tons) Forecast By Product Type, 2025 - 2032
  1. Small Boxes / Insulated Shippers
  2. Pallet Shippers / Pallets
  3. Large-Sized Pallet Containers
  4. Vaccines Vials & Packaging Systems
  5. Temperature-Controlled Bags & Pouches
  6. Others (Phase Change Materials, Gel Packs, etc.)
7. Current Market Size (US$ Mn) and Volume (Tons) Forecast By End Use Industry, 2025 - 2032
  1. Biopharmaceutical Companies
  2. Clinical Research Organizations (CROs)
  3. Hospitals & Healthcare Facilities
  4. Research Institutes & Laboratories
  5. Logistics & Distribution Companies
  6. Others (Vaccination Centers, Pharmacies)
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
  3. Apparent Production Capacity
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Sonoco Thermosafe
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Sealed Air
  3. Peli BioThermal Limited
  4. CSafe
  5. Intelsius
  6. Cryoport Systems, LLC
  7. Envirotainer
  8. SkyCell AG
  9. va-Q-tec AG
  10. Inmark Global Holdings, LLC
  11. Smurfit Westrock
  12. Insulated Products Corporation
  13. Chill-Pak
  14. Practical Packaging Solutions, Inc.
  15. TESSOL
  16. The Wool Packaging Company Limited
  17. Thermal Packaging Solutions Ltd.
  18. Hanchett Paper Company
  19. Topa Thermal
  20. Sofrigam
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Pharmaceutical Cold Chain Packaging Market Size, Share, and Growth Forecast, 2025 - 2032